Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000048

CEO bought 114,000 shares at an average $0.01 ($1,113)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-30 Purchase : show line 1 in the form +2,000 $0.01 $20 25,186,297 D
2019-08-30 Purchase : show line 2 in the form +2,000 $0.01 $20 25,188,297 D
2019-08-30 Purchase : show line 3 in the form +5,000 $0.01 $52 25,193,297 D
2019-09-03 Purchase : show line 4 in the form +5,000 $0.01 $51 25,198,297 D
2019-09-04 Purchase : show line 5 in the form +5,000 $0.01 $55 25,203,297 D
2019-09-04 Purchase : show line 6 in the form +5,000 $0.01 $50 25,208,297 D
2019-09-04 Purchase : show line 7 in the form +15,000 $0.01 $150 25,223,297 D
2019-09-04 Purchase : show line 8 in the form +5,000 $0.01 $50 25,228,297 D
Open-market purchases · 114,000 sh · avg $0.01 · $1,113
Loading xslF345X03/primary_doc.xml…